Genetic analysis identifies prognostic markers in CLLMay 28, 2019Leukemia, Myelodysplasia, Transplantation
NGS comparable to FC for minimal residual disease assessmentMay 17, 2019ALLPediatricsLeukemia, Myelodysplasia, Transplantation
FDA approves venetoclax/obinutuzumab combo for CLLMay 15, 2019Leukemia, Myelodysplasia, Transplantation
FDA panel not ready to recommend quizartinib approval for FLT3-ITD+ AMLMay 14, 2019AMLLeukemia, Myelodysplasia, Transplantation
Master trial seeks to aid drug development for pediatric AMLMay 12, 2019AMLLeukemia, Myelodysplasia, TransplantationPediatrics
Researchers propose new risk groups for NK-AMLMay 8, 2019AMLLeukemia, Myelodysplasia, Transplantation
Combo proves most effective in HMA-naive, higher-risk MDSMay 3, 2019Myelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationAML
More abnormal cells linked to poorer ASCT outcomes in MDSMay 3, 2019TransplantationMyelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
FDA approves ivosidenib frontline for certain AML patientsMay 3, 2019AMLLeukemia, Myelodysplasia, Transplantation
Biomarker testing may transform treatment of acute GVHDApril 26, 2019TransplantationLeukemia, Myelodysplasia, Transplantation
Idelalisib shows long-term safety, efficacy for relapsed CLLApril 26, 2019Leukemia, Myelodysplasia, Transplantation
Tagraxofusp produces high response rate in BPDCNApril 24, 2019Leukemia, Myelodysplasia, TransplantationALL
Complementary medicine use common among patients on TKIsApril 24, 2019CMLLeukemia, Myelodysplasia, Transplantation
Model inspired by Netflix, Amazon may help guide MDS treatmentApril 23, 2019Myelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
Sorafenib plus GCLAM held safe in AML, MDS phase-1 studyApril 22, 2019Leukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
